Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks
Saved in:
Main Authors: | Michael Migden, MD (Author), Carmen Loquai, MD, PhD (Author), Caroline Robert, MD, PhD (Author), Jean-François Baurain, MD, PhD (Author), Nicholas Squittieri, MD (Author), Ramon Arntz, Dr (Author), Jörg Dierlamm, BSc (Author), Brigitte Dréno, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib
by: Jaeyoung Yoon, MD, PhD, et al.
Published: (2018) -
Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy
by: Carlos González-Cruz, MD, et al.
Published: (2024) -
Optimizing the pharmacokinetics of sonidegib in small bowel syndrome and advanced basal cell carcinoma: Our solution
by: Hailey Grubbs, DO, et al.
Published: (2023) -
Microcystic adnexal carcinoma mimicking basal cell carcinomaKey message
by: Ximena Calderón-Castrat, MD, et al.
Published: (2017) -
Educational Case: Basal Cell Carcinoma
by: Katie A. O'Connell MS, et al.
Published: (2021)